Repligen Corp (RGEN)
183.70
-1.05
(-0.57%)
USD |
NASDAQ |
Mar 28, 16:00
184.08
+0.38
(+0.21%)
After-Hours: 20:00
Repligen Revenue (TTM): 638.76M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 638.76M |
September 30, 2023 | 669.78M |
June 30, 2023 | 729.33M |
March 31, 2023 | 777.80M |
December 31, 2022 | 801.54M |
September 30, 2022 | 801.30M |
June 30, 2022 | 778.77M |
March 31, 2022 | 734.10M |
December 31, 2021 | 670.53M |
September 30, 2021 | 592.66M |
June 30, 2021 | 508.50M |
March 31, 2021 | 433.01M |
December 31, 2020 | 366.26M |
September 30, 2020 | 327.09M |
June 30, 2020 | 302.47M |
March 31, 2020 | 285.70M |
December 31, 2019 | 270.24M |
September 30, 2019 | 252.71M |
June 30, 2019 | 232.80M |
March 31, 2019 | 209.84M |
December 31, 2018 | 194.03M |
September 30, 2018 | 183.70M |
June 30, 2018 | 170.75M |
March 31, 2018 | 155.48M |
December 31, 2017 | 141.24M |
Date | Value |
---|---|
September 30, 2017 | 125.22M |
June 30, 2017 | 113.32M |
March 31, 2017 | 110.04M |
December 31, 2016 | 104.54M |
September 30, 2016 | 100.39M |
June 30, 2016 | 95.53M |
March 31, 2016 | 87.81M |
December 31, 2015 | 83.54M |
September 30, 2015 | 78.48M |
June 30, 2015 | 73.94M |
March 31, 2015 | 68.04M |
December 31, 2014 | 63.55M |
September 30, 2014 | 62.54M |
June 30, 2014 | 66.08M |
March 31, 2014 | 68.04M |
December 31, 2013 | 68.17M |
September 30, 2013 | 71.60M |
June 30, 2013 | 67.88M |
March 31, 2013 | 65.90M |
December 31, 2012 | 62.27M |
September 30, 2012 | 52.08M |
June 30, 2012 | 44.63M |
March 31, 2012 | 35.02M |
September 30, 2011 | 29.26M |
June 30, 2011 | 27.93M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
209.84M
Minimum
Mar 2019
801.54M
Maximum
Dec 2022
519.16M
Average
550.58M
Median
Revenue (TTM) Benchmarks
Perspective Therapeutics Inc | 6.956M |
Retractable Technologies Inc | 41.99M |
Xtant Medical Holdings Inc | 78.46M |
Asensus Surgical Inc | 8.577M |
Catheter Precision Inc | -- |